Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GemOx-PDT in Advanced Cholangiocarcinoma
NCT00713687Phase 2Withdrawn
- Sponsor
- Technical University of Munich
- Start
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Photosan in cholangiocarcinoma (CCA), sponsored by Technical University of Munich. Primary endpoint: Progression Free Survival at 6 months. Planned start Aug 2008; status: withdrawn.
02
Drugs
Photosan
03
Conditions
cholangiocarcinoma (CCA)
Beyond the preview
Go deeper on NCT00713687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00713687.